Phorm taking even more money for ad targeting dream, now in China
Heard this one before? Controversial ISP-level web ads targeter Phorm is taking on more money to seek riches in another new country. But can it succeed in Asia where it has failed before?
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here